Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Clinical trial NCT05026736 · TERMINATED

Trial details

NCT number: NCT05026736
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Angiosarcoma Metastatic Angiosarcoma Recurrent Angiosarcoma

Start date: 2021-08-23
Primary completion: 2025-08-12
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.